1 / 8

Global Theranostics Market [By Disease Type (Neurological Disorders, Cardiovascular Diseases, Oncology Disorders, and Im

Global Theranostics Market [By Disease Type (Neurological Disorders, Cardiovascular Diseases, Oncology Disorders, and Immunological Disorders); By Technology (Polymerase Chain Reaction (PCR), In-situ Hybridization, Immunohistochemistry, and Sequencing); and by Regions]: Market size & Forecast, 2018 u2013 2026

Marketupdates
Download Presentation

Global Theranostics Market [By Disease Type (Neurological Disorders, Cardiovascular Diseases, Oncology Disorders, and Im

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Theranostics MarketSet to Exceed over USD 20.52 Billion by 2026 “Global Theranostics Market [By Disease Type (Neurological Disorders, Cardiovascular Diseases, Oncology Disorders, and Immunological Disorders); By Technology (Polymerase Chain Reaction (PCR), In-situ Hybridization, Immunohistochemistry, and Sequencing); and by Regions]: Market size & Forecast, 2018 – 2026”

  2. Theranostics Market Estimate & Forecast to 2026 The global theranostics market Size is anticipated to reach over USD 20.52 Billion by 2026 according to a new study published by Polaris Market Research. Theranostics are defined as a combination of diagnostics and drug therapeutics to improve the drug safety, drug restructures development and effectiveness. The combination of effective medical drugs and advanced diagnostic tests has been given numerous names, such as Dx/Rx partnering, integrated medicine, pharmacodiagnostics, and companion diagnostics. The increasing occurrence of life-threatening and chronic diseases and the demand for innovative chemotherapeutic treatments associated with the need for improving disease detection are the key factors propelling the global theranostics market. In addition, the rising potential of clinically adaptable nanomaterials in the biological imaging area and therapy is expected to bolster the market growth. Moreover, improved collaboration between drug and diagnostics firms are anticipated to enhance the growth of the theranostics market. In addition, a decrease in costs and reduced time required for medical trials monitored by pharmaceutical segments are another key drivers propelling the growth of the global theranostics market.

  3. Theranostics Market Scope Request for sample

  4. Theranostics Market Estimate & Forecast to 2026 The global theranostics market is segmented on the basis of disease type, technology, and geography. On the basis of disease type, the global theranostics market is segmented into Neurological Disorders, Cardiovascular Diseases, Oncology Disorders, and Immunological Disorders. On the basis of disease type, the oncology segment is anticipated to boost the market growth. Increasing cancer cases and theranostics potentials to make effective cancer care are the factors associated with the market growth. On the basis of technology, the global theranostics market is segmented into Polymerase Chain Reaction (PCR), In-situ Hybridization, Immunohistochemistry, and sequencing. In 2017, the PCR is anticipated to dominate the market growth. The existence of a robust evaluate assortment in terms of polymerase chain reaction (PCR) is accountable for the larger market share. Some major key players in global theranostics market include F Hoffman La Roche, Thermo Fisher Scientific Inc., GE Healthcare, Agilent Technologies, Qiagen NV, Foundation Medicine, Leica Biosystems NusslochGmBH, and Pfizer, Inc. among others. Browse Complete Report

  5. Theranostics Market Share Request for TOC

  6. Theranostics Market Study – Engagement Options Buy Now – Click Here! Buy now & have immediate access to premium insights Purchase Report Sections – Click Here! Regional analysis Segmentation analysis Industry outlook Competitive landscape Speak To Analyst – Click Here! Get your doubts clear Schedule a call with our analyst before making any decision Request For Sample Pages – Click Here! Get free sample pages Understand report structure Unmask data for validation

  7. About Us Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to e present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com/

  8. Thank You! Contact Us : Polaris Market Research30 Wall Street8th Floor, New York City, NY 10005,United States E mail Id: sales@polarismarketresearch.com Phone: +1-646-568-9980

More Related